Veracyte Future Growth
Future criteria checks 4/6
Veracyte is forecast to grow earnings and revenue by 59.3% and 9.7% per annum respectively. EPS is expected to grow by 60.4% per annum. Return on equity is forecast to be 1.7% in 3 years.
Key information
59.3%
Earnings growth rate
60.4%
EPS growth rate
Biotechs earnings growth | 36.0% |
Revenue growth rate | 9.7% |
Future return on equity | 1.7% |
Analyst coverage | Good |
Last updated | 24 Oct 2024 |
Recent future growth updates
Recent updates
Earnings and Revenue Growth Forecasts
Date | Revenue | Earnings | Free Cash Flow | Cash from Op | Avg. No. Analysts |
---|---|---|---|---|---|
12/31/2026 | 529 | 53 | 89 | 115 | 8 |
12/31/2025 | 480 | 31 | 86 | 101 | 10 |
12/31/2024 | 436 | 14 | 54 | 63 | 10 |
6/30/2024 | 400 | -54 | 40 | 50 | N/A |
3/31/2024 | 375 | -68 | 26 | 37 | N/A |
12/31/2023 | 361 | -74 | 34 | 44 | N/A |
9/30/2023 | 343 | -50 | 29 | 38 | N/A |
6/30/2023 | 329 | -29 | 23 | 31 | N/A |
3/31/2023 | 311 | -30 | 7 | 14 | N/A |
12/31/2022 | 297 | -37 | -1 | 8 | N/A |
9/30/2022 | 284 | -43 | -1 | 6 | N/A |
6/30/2022 | 268 | -49 | -10 | -2 | N/A |
3/31/2022 | 251 | -48 | -7 | 0 | N/A |
12/31/2021 | 220 | -76 | -37 | -32 | N/A |
9/30/2021 | 187 | -73 | -43 | -38 | N/A |
6/30/2021 | 157 | -63 | -39 | -35 | N/A |
3/31/2021 | 123 | -65 | -48 | -45 | N/A |
12/31/2020 | 117 | -35 | -13 | -10 | N/A |
9/30/2020 | 113 | -34 | -13 | -10 | N/A |
6/30/2020 | 113 | -31 | -16 | -13 | N/A |
3/31/2020 | 122 | -22 | -10 | -8 | N/A |
12/31/2019 | 120 | -13 | -6 | -3 | N/A |
9/30/2019 | 116 | -8 | -8 | -6 | N/A |
6/30/2019 | 109 | -12 | -9 | -6 | N/A |
3/31/2019 | 101 | -16 | -10 | -7 | N/A |
12/31/2018 | 92 | -23 | -15 | -14 | N/A |
9/30/2018 | 86 | -28 | -20 | -18 | N/A |
6/30/2018 | 80 | -31 | -23 | -21 | N/A |
3/31/2018 | 76 | -32 | N/A | -23 | N/A |
12/31/2017 | 72 | -31 | N/A | -24 | N/A |
9/30/2017 | 71 | -27 | N/A | -22 | N/A |
6/30/2017 | 72 | -26 | N/A | -25 | N/A |
3/31/2017 | 68 | -29 | N/A | -27 | N/A |
12/31/2016 | 65 | -31 | N/A | -28 | N/A |
9/30/2016 | 61 | -35 | N/A | -27 | N/A |
6/30/2016 | 55 | -38 | N/A | -23 | N/A |
3/31/2016 | 52 | -36 | N/A | -27 | N/A |
12/31/2015 | 50 | -34 | N/A | -27 | N/A |
9/30/2015 | 48 | -34 | N/A | -33 | N/A |
6/30/2015 | 45 | -33 | N/A | -35 | N/A |
3/31/2015 | 42 | -30 | N/A | -30 | N/A |
12/31/2014 | 38 | -29 | N/A | -28 | N/A |
9/30/2014 | 33 | -27 | N/A | -22 | N/A |
6/30/2014 | 29 | -26 | N/A | -21 | N/A |
3/31/2014 | 25 | -25 | N/A | -19 | N/A |
12/31/2013 | 22 | -26 | N/A | -19 | N/A |
Analyst Future Growth Forecasts
Earnings vs Savings Rate: 12V is forecast to become profitable over the next 3 years, which is considered faster growth than the savings rate (0.8%).
Earnings vs Market: 12V is forecast to become profitable over the next 3 years, which is considered above average market growth.
High Growth Earnings: 12V is expected to become profitable in the next 3 years.
Revenue vs Market: 12V's revenue (9.7% per year) is forecast to grow faster than the German market (5.5% per year).
High Growth Revenue: 12V's revenue (9.7% per year) is forecast to grow slower than 20% per year.
Earnings per Share Growth Forecasts
Future Return on Equity
Future ROE: 12V's Return on Equity is forecast to be low in 3 years time (1.7%).